Technical information
Manufacturer
Laboratoires PROSTRAKAN PHARMA
Presentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
MEVMxu0LDgFt5Njt